Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Feb 21, 2015; 21(7): 2096-2101
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2096
Table 1 Patient characteristics
CharacteristicsPatients (n)
Median age (range) (yr)60 (39-72)
Sex
Male6
Female7
ECOG performance status
03
18
22
Median CA 19-9 level (range) (ng/mL)73 (2-4472)
Previous chemotherapy
Intravenous gemcitabine oxaliplatin13
Intra-arterial gemcitabine oxaliplatin5
Tumor limiting the liver
Yes4
No9
Table 2 Observed toxicity according National Cancer Institute Common Terminology Criteria for adverse events grading (n = 12)
NCI-CTC grade
All gradesSevere1
Hematological
Anemia50
Neutropenia73
Thrombocytopenia62
Non hematological
Nausea/vomiting60
Mucositis10
Diarrhea52
Infection00
Nose bleeding20
High blood pressure20